Pulse Rate and Breathing Rate Accuracy

Pulse Rate and Breathing Rate Accuracy Study - NuraLogix AMC-SDK

NCT06298981•Nuralogix Corporation

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Pulse Rate and Breathing Rate

Interventions

noninvasive and investigational NuraLogix AMC-SDK

Locations

United States

Locations (1)

Element Materials Technology

Louisville, Colorado, United States

Key Dates

Start Date

February 12, 2024

Primary Completion Date

June 30, 2024

Completion Date

June 30, 2024

Last Updated

March 22, 2024

Contacts

Roberto Liddi

CONTACT

(647) 578-7925 robertoliddi@nuralogix.ai

Sponsors

Lead Sponsor

Nuralogix Corporation

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 22, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions